Cargando…
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer
Cancer cells can become resistant to existing treatments over time, so it is important to develop new treatments that target different pathways to stay ahead of this resistance. Many cancer treatments have severe side effects that can be debilitating and even life-threatening. Developing drugs that...
Autores principales: | Elmetwalli, Alaa, Hashish, Shimaa Mustafa, Hassan, Mervat G., El-Magd, Mohammed Abu, El-Naggar, Sabry Ali, Tolba, Amina M., Salama, Afrah Fatthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567854/ https://www.ncbi.nlm.nih.gov/pubmed/37160480 http://dx.doi.org/10.1007/s00210-023-02511-8 |
Ejemplares similares
-
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage
por: Attia, Attia Ahmed, et al.
Publicado: (2022) -
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action
por: Elmetwalli, Alaa, et al.
Publicado: (2023) -
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents
por: Elmetwalli, Alaa, et al.
Publicado: (2023) -
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
por: El-Sewedy, Tarek, et al.
Publicado: (2023) -
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches
por: El-Shehawy, Ashraf A., et al.
Publicado: (2023)